CM
EUCR

Cohanzick Management’s Eucrates Biomedical Acquisition Corp. Ordinary Shares EUCR Stock Holding History

Cohanzick Management’s Portfolio EUCR Stock Details EUCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,649
Closed -$26K – 360
2022
Q2 		$26K Buy
2,649
+99
+4% +$972 0.01% 298
2022
Q1 		$25K Buy
2,550
+400
+19% +$3.92K 0.01% 356
2021
Q4 		$21K Buy
+2,150
New +$21K ﹤0.01% 340